Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial-Reference-Cited by-同舟云学术

Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial

Published:2017-01-20 Issue:3 Volume:49 Page:499-507
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Ren Hong,Li Xiao,Ni Zhao-Hui,Niu Jian-Ying,Cao Bin,Xu Jie,Cheng Hong,Tu Xiao-Wen,Ren Ai-Min,Hu Ying,Xing Chang-Ying,Liu Ying-Hong,Li Yan-Feng,Cen Jun,Zhou Rong,Xu Xu-Dong,Qiu Xiao-Hui,Chen Nan

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11255-017-1507-0.pdf

Reference18 articles.

1. Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49:53–70

2. Singh KP, Li G, Mitrani-gold FS et al (2013) Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection. Antimicrob Agents Chemother 57:5284–5290

3. Moriel DG, Schembri MA (2013) Vaccination approaches for the prevention of urinary tract infection. Curr Pharm Biotechnol 14:967–974

4. Hu FP, Zhu DM, Wang Fu et al (2014) CHINET 2013 surveillance of bacterial resistance in China. Chin J Infect Chemother 14:365–374

5. Mcgregor JC, Allen GP, Bearden DT (2008) Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Ther Clin Risk Manag 4:843–853

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines;European Urology;2024-07

2. Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review;Antibiotics;2023-08-19

3. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18

4. Harnwegsinfektionen;Therapie-Handbuch - Infektionskrankheiten und Schutzimpfungen;2023

5. The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens;Expert Review of Anti-infective Therapy;2022-09-21